Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ruta, Rao"'
Autor:
Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan F. Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobagyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee Schwartzberg, Michael S. Broder
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Hyperglycemia and rash are expected but challenging adverse events of phosphatidylinositol-3-kinase inhibition (such as with alpelisib). Two modified Delphi panels were conducted to provide consensus recommendations for managing hyperglycemi
Externí odkaz:
https://doaj.org/article/8183fb8cce4340f9881e7c5f5b6eef4c
Autor:
Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Background Soluble urokinase plasminogen activator receptor is an inflammatory biomarker that may prognosticate cardiovascular outcomes. We sought to determine the associations between soluble urokinase plasminogen activator receptor and est
Externí odkaz:
https://doaj.org/article/2371ba59380f4e9bacff0d2c6bfd133e
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 4954-4965 (2022)
Abstract Background Accurate diagnostic biomarker testing is crucial to treatment decisions in breast cancer. Biomarker testing is performed on core needle biopsies (CNB) and is often repeated in the surgical specimen (SS) after resection. As differe
Externí odkaz:
https://doaj.org/article/e731e81538ff49b092098380493e0cdd
Autor:
Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/093cf72e74ff43ee9aace492fdb7973b
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 399-402 (2022)
Many patients with metastatic breast cancer develop liver metastases. A rare complication of this is hepatopulmonary syndrome (HPS), which is associated with exertional dyspnea and intrapulmonary shunting. We present a patient who presented with HPS
Externí odkaz:
https://doaj.org/article/e7adb08c7fc34f0586d5dc9cb06503ad
Autor:
Patricia A. Robinson, Ruta Rao, Vasilios Vasilopoulos, Sandra L. Gomez-Perez, Joy S. Sclamberg, M. Bojko, Cara Joyce, A. Smith, Patricia M. Sheean, Paula O'Connor
Publikováno v:
Breast Cancer Research and Treatment. 190:121-132
To examine the relationship between skeletal muscle (SM) and cancer-specific outcomes for women with estrogen receptor-negative (ER−) metastatic breast cancer (MBC). For this retrospective cohort, females (≥ 18 years) with histologically confirme
Publikováno v:
Cancer Research. 81:PS2-34
Accurate diagnostic biomarker testing, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2) expression profile, is crucial to appropriate management decisions in breast cancer. Receptor sta
Autor:
Jennifer Poirier, Katherine Kopkash, Laurel L. Tangalakis, Andrea Madrigrano, Ruta Rao, Xuanji Wang, Ashley A. Woodfin, Jennifer D. Son, Chandler S. Cortina
Publikováno v:
Breast Care (Basel)
Introduction: Breast cancer is the second most common cause of cancer death in females, and 30% of these patients are over the age of 70 years. Studies have shown deviation from the standard treatment paradigms in the elderly, especially in regard to
Autor:
Jian H Chu, Lillian Tung, melody cobleigh, Ruta Rao, Steven B Feinstein, Lydia Usha, April Swoboda, Jochen Reiser, Tochi M Okwuosa
Publikováno v:
Circulation. 144
Introduction: Elevated soluble urokinase type plasminogen activator (suPAR) is a risk factor for renal and cardiovascular (CV) diseases in the general population. Hypothesis: We evaluated associations between suPAR and markers of subclinical cardioto
Autor:
Chandler S. Cortina, Andrea Madrigrano, Surbhi Agarwal, Ruta Rao, Laurel Mulder, Jennifer Poirier, David Ansell
Publikováno v:
Clinical Breast Cancer. 18:e1289-e1292
Background The Cancer and Leukemia Group B (CALGB) 9343 clinical trial proved that omission of radiotherapy (RT) in patients 70 and older with T1cN0M0, estrogen receptor-positive tumors who undergo breast conservation therapy (BCT) and receive 5 year